Cargando…
Aberrant E-cadherin staining patterns in invasive mammary carcinoma
BACKGROUND: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on chromosome 16q22 are associated with changes in E-cadherin protein expression and function. Inactivation o...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308872/ https://www.ncbi.nlm.nih.gov/pubmed/16287501 http://dx.doi.org/10.1186/1477-7819-3-73 |
_version_ | 1782126300417228800 |
---|---|
author | Harigopal, Malini Shin, Sandra J Murray, Melissa P Tickoo, Satish K Brogi, Edi Rosen, Paul Peter |
author_facet | Harigopal, Malini Shin, Sandra J Murray, Melissa P Tickoo, Satish K Brogi, Edi Rosen, Paul Peter |
author_sort | Harigopal, Malini |
collection | PubMed |
description | BACKGROUND: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on chromosome 16q22 are associated with changes in E-cadherin protein expression and function. Inactivation of E-cadherin in lobular carcinomas and certain diffuse gastric carcinomas may play a role in the dispersed, discohesive "single cell" growth patterns seen in these tumors. The molecular "signature" of mammary lobular carcinomas is the loss of E-cadherin protein expression as evidenced by immunohistochemistry, whereas ductal carcinomas are typically E-cadherin positive. PATIENTS AND METHODS: We report on E-cadherin immunostaining patterns in five cases of invasive mammary carcinoma RESULTS: These were five exceptional instances in which the E-cadherin immunophenotype did not correspond to the apparent histologic classification of the lesion. These cases which are exceedingly rare in our experience are the subject of this report. CONCLUSION: Findings such as those illustrated in this study occur in virtually all biologic phenomena and they do not invalidate the very high degree of correlation between the expression of E-cadherin and the classification of breast carcinomas as ductal or lobular type on the basis of conventional histologic criteria. |
format | Text |
id | pubmed-1308872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-13088722005-12-08 Aberrant E-cadherin staining patterns in invasive mammary carcinoma Harigopal, Malini Shin, Sandra J Murray, Melissa P Tickoo, Satish K Brogi, Edi Rosen, Paul Peter World J Surg Oncol Research BACKGROUND: E-cadherin, a cell surface protein involved in cell adhesion, is present in normal breast epithelium, benign breast lesions, and in breast carcinoma. Alterations in the gene CDH1 on chromosome 16q22 are associated with changes in E-cadherin protein expression and function. Inactivation of E-cadherin in lobular carcinomas and certain diffuse gastric carcinomas may play a role in the dispersed, discohesive "single cell" growth patterns seen in these tumors. The molecular "signature" of mammary lobular carcinomas is the loss of E-cadherin protein expression as evidenced by immunohistochemistry, whereas ductal carcinomas are typically E-cadherin positive. PATIENTS AND METHODS: We report on E-cadherin immunostaining patterns in five cases of invasive mammary carcinoma RESULTS: These were five exceptional instances in which the E-cadherin immunophenotype did not correspond to the apparent histologic classification of the lesion. These cases which are exceedingly rare in our experience are the subject of this report. CONCLUSION: Findings such as those illustrated in this study occur in virtually all biologic phenomena and they do not invalidate the very high degree of correlation between the expression of E-cadherin and the classification of breast carcinomas as ductal or lobular type on the basis of conventional histologic criteria. BioMed Central 2005-11-14 /pmc/articles/PMC1308872/ /pubmed/16287501 http://dx.doi.org/10.1186/1477-7819-3-73 Text en Copyright © 2005 Harigopal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Harigopal, Malini Shin, Sandra J Murray, Melissa P Tickoo, Satish K Brogi, Edi Rosen, Paul Peter Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
title | Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
title_full | Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
title_fullStr | Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
title_full_unstemmed | Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
title_short | Aberrant E-cadherin staining patterns in invasive mammary carcinoma |
title_sort | aberrant e-cadherin staining patterns in invasive mammary carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308872/ https://www.ncbi.nlm.nih.gov/pubmed/16287501 http://dx.doi.org/10.1186/1477-7819-3-73 |
work_keys_str_mv | AT harigopalmalini aberrantecadherinstainingpatternsininvasivemammarycarcinoma AT shinsandraj aberrantecadherinstainingpatternsininvasivemammarycarcinoma AT murraymelissap aberrantecadherinstainingpatternsininvasivemammarycarcinoma AT tickoosatishk aberrantecadherinstainingpatternsininvasivemammarycarcinoma AT brogiedi aberrantecadherinstainingpatternsininvasivemammarycarcinoma AT rosenpaulpeter aberrantecadherinstainingpatternsininvasivemammarycarcinoma |